Protein Structure and Folding
Selective Recruitment of an E2∼Ubiquitin Complex by an E3 Ubiquitin Ligase*

https://doi.org/10.1074/jbc.M112.353748Get rights and content
Under a Creative Commons license
open access

RING E3 ligases are proteins that must selectively recruit an E2-conjugating enzyme and facilitate ubiquitin transfer to a substrate. It is not clear how a RING E3 ligase differentiates a naked E2 enzyme from the E2∼ubiquitin-conjugated form or how this is altered upon ubiquitin transfer. RING-box protein 1 (Rbx1/ROC1) is a key protein found in the Skp1/Cullin-1/F-box (SCF) E3 ubiquitin ligase complex that functions with the E2 ubiquitin conjugating enzyme CDC34. The solution structure of Rbx1/ROC1 revealed a globular RING domain (residues 40–108) stabilized by three structural zinc ions (root mean square deviation 0.30 ± 0.04 Å) along with a disordered N terminus (residues 12–39). Titration data showed that Rbx1/ROC1 preferentially recruits CDC34 in its ubiquitin-conjugated form and favors this interaction by 50-fold compared with unconjugated CDC34. Furthermore, NMR and biochemical assays identified residues in helix α2 of Rbx1/ROC1 that are essential for binding and activating CDC34∼ubiquitin for ubiquitylation. Taken together, this work provides the first direct structural and biochemical evidence showing that polyubiquitylation by the RING E3 ligase Rbx1/ROC1 requires the preferential recruitment of an E2∼ubiquitin complex and subsequent release of the unconjugated E2 protein upon ubiquitin transfer to a substrate or ubiquitin chain.

E3 Ubiquitin Ligase
Enzyme Mechanisms
Protein Complexes
Structural Biology
Ubiquitin Conjugating Enzyme (Ubc)
Ubiquitination

Cited by (0)

Author's Choice—Final version full access.

The atomic coordinates and structure factors (code 2LGV) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

NMR assignments for sRbx112-108 were deposited to the BioMagResBank (BMRB 17824).

*

This work was supported by Canadian Cancer Society Grant CCS-018414, Canadian Institutes of Health Research Grant MOP-14606, and by the Canada Research Chairs Program (to G. S. S.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM061051 and CA095634 (to Z.-Q. P.).

This article contains supplemental Figs. 1 and 2.

1

Recipient of a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship and an Ontario Ministry of Research and Technology postdoctoral fellowship.